CST Brands, Inc. CST
Set alert
48.53 0.00 0.00%
At close · Jun 28
48.53 Day range 48.54
42.52 52-week range 48.56
- Open
- 48.53
- Prev close
- 48.53
- Mkt cap
- 3.68B
- Vol
- 652.32K
- Avg vol
- 559.17K
- EPS
- 4.08
- P/E
- 12.03
- Div yield
- 0.00%
More statistics
- Low
- 48.53
- High
- 48.54
- Forward P/E
- 18.52
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 48.41
- 200-d avg
- 48.31
- 1y target
- 0.00
Key statistics
- Market cap
- 3.68B
- Enterprise value
- 0
- Trailing P/E
- 12.03
- Forward P/E
- 18.52
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 48.41
- 200-day average
- 48.31
Analyst view
Consensus: none
Price target (mean) 0.00
Financials — quick view
CST Revenue — quarterly 2.80B
CST Net income — quarterly 3.00M
CST EPS — quarterly 0.04
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 30, 2016 | Mar 31, 2017 | — | 0.0396 | — | — |
| Nov 7, 2016 | Sep 30, 2016 | — | 3.44 | — | — |
| Sep 29, 2016 | Dec 31, 2016 | — | 0.24 | — | — |
| Aug 4, 2016 | Jun 30, 2016 | — | 0.36 | — | — |
| May 5, 2016 | Mar 31, 2016 | — | 0.25 | — | — |
| Feb 18, 2016 | Dec 31, 2015 | — | 0.33 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 22, 2016 | Gabelli & Co | down | Buy | Hold |
| Aug 22, 2016 | Macquarie | down | Outperform | Neutral |
| Aug 21, 2016 | Wells Fargo | down | Outperform | Market Perform |
| Aug 21, 2016 | Mizuho | down | Buy | Neutral |
| Jul 24, 2016 | Raymond James | down | Outperform | Mkt Perform |
| Apr 7, 2016 | Jefferies | init | — | Hold |
News
- Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic
- Is Carrier Global (CARR) 7.2% Undervalued After Q1 2026 Beat? Adjusted EPS $0.57 vs $0.39, Revenue $5.34B vs $5.01B; GF Score 82/100
- Azure Holding Group 1st Quarter Earnings Report
- Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema
- CST Brands to Announce Second Quarter 2016 Earnings Results on August 5
- CST Brands to Announce First Quarter 2016 Earnings Results on May 6
- CST Brands and CrossAmerica Partners to Announce Year-End and Fourth Quarter 2015 Earnings Results on February 19
- CST Brands and CrossAmerica Partners to Announce Third Quarter 2015 Earnings Results on November 4
- CST Brands and CrossAmerica Partners to Announce Second Quarter 2015 Earnings Results on August 7
- CST Brands and CrossAmerica Partners to Announce First Quarter 2015 Earnings Results on May 8
Your note
Sign in to keep a note on CST — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADAMS CHARLES (HAL) | Officer | Disposition (Non Open Market) | Jun 27, 2017 | 11,310 |
| BARTYS ANTHONY P | Officer | Option Exercise | Jun 27, 2017 | 19,248 |
| BOLES DONNA M | Director | Option Exercise | Jun 27, 2017 | 14,977 |
| BURTON ROGER G | Director | Option Exercise | Jun 27, 2017 | 14,977 |
| DEWBRE ROCKY | Director | Option Exercise | Mar 7, 2017 | 8,683 |
| DICKSON THOMAS W | Director | Option Exercise | Jun 27, 2017 | 3,483 |